What’s the future of the drugs our population will need, and how will we be able to find them? Co-founder of AbCellera, Kevin Heyries, shares some of the challenges facing global health and how innovation and new technologies like AbCellera’s antibody discovery platform can overcome them. With the world’s leading technology to search for antibody drug candidates from natural immune responses, AbCellera can discover antibodies with unique therapeutic properties faster and better than conventional technologies.
